INPPL1 and metabolic syndrome: The authors of one study suggest that SHIP2 polymorphisms may take part in the pathogenesis of several diseases, which are primarily caused by disturbances in glucose and insulin homeostasis, like diabetes mellitus type 2 (DMT2) and metabolic syndrome as well as hypertension [19].